אודנטרון

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE

Commercializzato da:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Codice ATC:

A04AA01

Forma farmaceutica:

תמיסה להזרקה

Composizione:

ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2 MG/ML

Via di somministrazione:

תוך-ורידי, תוך-שרירי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

KLEVA S.A., GREECE

Gruppo terapeutico:

ONDANSETRON

Area terapeutica:

ONDANSETRON

Indicazioni terapeutiche:

Adults: Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV).Paediatric Population: Odantron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ?6 months, and for the prevention and treatment of PONV in children aged ?2 years.

Data dell'autorizzazione:

2018-07-31